|
VISITRON Inc
yokogawa csu22 spinning disc module Yokogawa Csu22 Spinning Disc Module, supplied by VISITRON Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/yokogawa+csu+x1+a1+nipkow+spinning+disc+unit/10__1128_slash_jvi__00234___15-89-10-26 Average 90 stars, based on 1 article reviews
yokogawa csu22 spinning disc module - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Evident Corporation
bx61 microscope Bx61 Microscope, supplied by Evident Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/BX61WI%2FBX51WI+Fixed+Stage+Microscope/pm24599893-87-16-19 Average 90 stars, based on 1 article reviews
bx61 microscope - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd138 microbeads ![]() Cd138 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/CD138+MicroBeads%2C+mouse/pm21184800-51-0-5 Average 95 stars, based on 1 article reviews
cd138 microbeads - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
MedChemExpress
ova peptide ![]() Ova Peptide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/OVA+Peptide/pmc13121634-612-35-41 Average 94 stars, based on 1 article reviews
ova peptide - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
recombinant rat arfgap1 protein ![]() Recombinant Rat Arfgap1 Protein, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/Phospho-p53+(Ser15)+Rabbit+mAb/pm22363216-376-96-128 Average 93 stars, based on 1 article reviews
recombinant rat arfgap1 protein - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Hamamatsu
nanozoomer 2.0 ht 257 ![]() Nanozoomer 2.0 Ht 257, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/nanozoomer/pmc11513845__mmc4-541-71-77 Average 90 stars, based on 1 article reviews
nanozoomer 2.0 ht 257 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
MedChemExpress
rimonabant ![]() Rimonabant, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/Rimonabant/bio_rxiv__2024__07__31__605567-227-4-19 Average 93 stars, based on 1 article reviews
rimonabant - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
phospho mkk4 ![]() Phospho Mkk4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/Phospho-SEK1%2FMKK4+(Thr261)+Antibody/pmc06117259-255-30-98 Average 93 stars, based on 1 article reviews
phospho mkk4 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Edmund Optics
1951 usaf bar target nt38-257 ![]() 1951 Usaf Bar Target Nt38 257, supplied by Edmund Optics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/zoom+lens+nt58+240/pmc03058353-617-18-21 Average 90 stars, based on 1 article reviews
1951 usaf bar target nt38-257 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
JEOL
transmission electron microscopy tem ![]() Transmission Electron Microscopy Tem, supplied by JEOL, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/JEOL-IDES_Products+Transmission+Electron+Microscope/pm19703784-28-13-19 Average 99 stars, based on 1 article reviews
transmission electron microscopy tem - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
MedChemExpress
fluorescein phalloidin ![]() Fluorescein Phalloidin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/Fluorescein+Phalloidin/pm41491488-94-9-14 Average 94 stars, based on 1 article reviews
fluorescein phalloidin - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Edmund Optics
aspheric lens edmund optics 67-257 ![]() Aspheric Lens Edmund Optics 67 257, supplied by Edmund Optics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/257+microscope/aspheric+lenses+edmund+optics++88+284/10__1117_slash_1__nph__10__4__044303-208-21-24 Average 90 stars, based on 1 article reviews
aspheric lens edmund optics 67-257 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Experimental hematology
Article Title: The polo-like kinase inhibitor BI 2536 exhibits potent activity against malignant plasma cells and represents a novel therapy in multiple myeloma.
doi: 10.1016/j.exphem.2010.12.006
Figure Lengend Snippet: Figure 4. BI 2536 causes apoptosis, endoduplication, and caspase-8 activation in MM cells. (A) MM.1S cells were treated with 10 nM and 100 nM BI 2536 for 24 hours then analyzed for Annexin-V and propidium iodide expression by flow cytometry. (B) Cells were plated in 100 nM BI 2536 for 48 hours then immunolabeled using fluorescein isothiocyanatelinked antiAnnexin-V and stained with propidium iodide. Photos were taken using a Leica DM 5000B microscope fitted with a Leica DPC300FX digital camera using a 40 objective. Images were captured using Leica application suite software. Scale bar: 10 mm. (C) MM.1S cells were analyzed by propidium iodide (PI) cell-cycle analysis. This reveals an increased proportion of 4N cells in G2/M and a population of 8N cells indicative of endoreduplication by 24 hours. (D) CD138þ patient cells were plated at a density of 10,000 cells per well in 96-well plates and assayed for caspase-8 activation.
Article Snippet:
Techniques: Activation Assay, Expressing, Cytometry, Immunolabeling, Staining, Microscopy, Software, Cell Cycle Assay
Journal: Signal Transduction and Targeted Therapy
Article Title: Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer
doi: 10.1038/s41392-026-02641-4
Figure Lengend Snippet: Macrophage efferocytosis function influences antigen presentation ability through MHC-I. a BMDMs from C57BL/6 mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC-GFP cells for 12 hours, then analyzed by flow cytometry for GFP uptake. Bar plot shows gMFI of GFP in BMDMs treated with MerTK inhibitor vs control ( n = 3). One-way ANOVA with Dunnett’s test compared MerTKi groups to control. Data are presented by mean ± SD. b BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP cells for 12 hours, treated with MerTK inhibitor, then co-cultured with CD8 + T cells from OT1 mice for 24 hours. Flow cytometry detected MHC-I, SIINFEKL loading, CD80, CD86 on BMDMs. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. c Flow cytometry detection of Tetramer + , PD-1 + , Tim-3 + , and GZMB + cells after co-culture of BMDMs with OT1 CD8 + T cells. Bar plot shows differences between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. d Apoptotic KPC cells induced by chemotherapy and labeled with Caspase3/7 green were co-cultured with BMDMs. Phagolysosome formation was detected using pHrodo red. Representative fluorescence microscopy images (1000x) show differences between MerTK inhibitor and control groups ( n = 6). Green: Caspase3/7, Red: pHrodo, Blue: DAPI. White scale bar= 20 μm. e Bar plots show total pHrodo fluorescence intensity (left) and the number of Caspase3/7 + pHrodo + vesicles per cell (right) in BMDMs after incubation with apoptotic cells ( n = 6). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. f Flow cytometry analysis of pHrodo gMFI in BMDMs after incubation with apoptotic cells. Bar plot shows pHrodo gMFI levels between MerTK inhibitor and control groups ( n = 3). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. g Violin-box plots of lysosome-associated gene transcript expression in macrophage subpopulations from scRNA sequencing data. Solid lines represent medians and quartiles. One-way ANOVA with Kruskal-Wallis H test compared groups (Mac_cl1 as reference). h , i BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, co-cultured with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours. After removing apoptotic cells, RNA was extracted for qPCR. Bar plots show transcript differences between Gpr34 +/+ and Gpr34 −/− BMDMs ( h ) efferocytosis receptors, ( i ) lysosome-related/transcription factors, ( n = 3). Two-tailed unpaired t-test was used. Data are presented by mean ± SD. j BMDMs from C57BL/6 mice were cultured until day 5, transiently transfected with siRNA, then co-incubated with TCM and chemotherapy-induced apoptotic KPC cells for 12 hours and analyzed by flow cytometry. Bar plot shows differences in MHC-I protein levels between knockdown and control groups ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. k BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with lysosomal inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Bar plot shows pHrodo gMFI in macrophages from flow cytometry, comparing lysosomal inhibitor group vs control. One-way ANOVA with Dunnett’s test was used . Data are presented by mean ± SD. l , m Flow cytometry detection of macrophage antigen presentation function ( l ) and CD8 + T cell specific killing capacity ( m ) in the BMDM-OT1 CD8 + T cell co-culture system. Bar plots show differences between lysosomal inhibitor and control groups. One-way ANOVA with Dunnett ’ s test was used. Data are presented by mean ± SD. n BMDMs from C57BL/6 mice were cultured until day 5, co-incubated with TCM, MerTK inhibitor/Lysosome inhibitor and chemotherapy-induced apoptotic KPC cells for 12 hours. Bar plot shows differences in MHC-I protein levels between different groups detected by flow cytometry ( n = 3). One-way ANOVA with post-hoc Tukey’s test was used. Data are presented by mean ± SD. o –q BMDMs from Gpr34 +/+ and Gpr34 −/− mice were cultured until day 5, transiently transfected with Cxcl16 siRNA, co-incubated with TCM, LysoPS and chemotherapy-induced apoptotic KPC-OVA-GFP for 12 hours, treated with MerTK inhibitor, then co-cultured with OT1 CD8 + T cells for 24 hours. Flow cytometry detected CD8 + T cell specific killing function (o ), cytotoxic function ( p ), and exhaustion levels ( q ). One-way ANOVA with Dunnett’s test was used. Data are presented by mean ± SD. NS no significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
Article Snippet: For BMDM and OT-1 CD8 + T cell co-culture, BMDMs from OT-1 mice (8 weeks) were isolated and cultured according to standard methods, and the stimulation reached No. At 5 days, BMDMs were stimulated with
Techniques: Immunopeptidomics, Cell Culture, Flow Cytometry, Control, Incubation, Co-Culture Assay, Labeling, Fluorescence, Microscopy, Expressing, Sequencing, Two Tailed Test, Transfection, Knockdown
Journal: PLoS genetics
Article Title: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
doi: 10.1371/journal.pgen.1002526
Figure Lengend Snippet: Figure 1. LRRK2 interacts with ArfGAP1 in mammalian cells and in vivo. (A) YFP-tagged ArfGAP1 (WT or DN) interacts with full-length FLAG- tagged LRRK2 following immunoprecipitation (IP) with anti-FLAG antibody from HEK-293T cells. Domain organization of ArfGAP1 constructs is indicated. (B) Interaction of ArfGAP1-YFP (WT or DN) and FLAG-LRRK2 following reverse IP with anti-GFP antibody from HEK-293T cells. (C) Domain mapping reveals the interaction of ArfGAP1-YFP with full-length (WT) LRRK2 and residues 480–895 of LRRK2 (fragment F2) following IP with anti-FLAG antibody from HEK-293T cells. Domain organization of LRRK2 deletion mutants is indicated. (D) Myc-a-synuclein fails to interact with ArfGAP1-YFP following IP with anti-myc antibody from HEK-293T cells. (E) LRRK2 interacts with ArfGAP1 in cerebral cortex extracts from WT mice but not LRRK2 knockout (KO) mice following IP with anti-LRRK2 antibody (clone c41-2). (F) ArfGAP1 interacts with LRRK2 in mouse cerebral cortex following IP with anti-ArfGAP1 antibody but not with a rabbit IgG control. IgG light chain (LC) indicates the equivalent amounts of IgG used for IP. Molecular mass markers are indicated in kilodalton (kDa). Data are representative of at least two independent experiments. doi:10.1371/journal.pgen.1002526.g001
Article Snippet: The following antibodies were employed: mouse monoclonal anti-FLAG-(M2), anti-FLAG-(M2)peroxidase, anti-TH (clone TH-2), anti-MAP2 (clone HM-2) and anti-b-tubulin (clone TUB 2.1), and rabbit polyclonal anti-MAP2 and reagent grade IgG from rabbit serum (Sigma-Aldrich, Buchs, Switzerland); mouse monoclonal anti-GFP (clones 7.1 and 13.1), anti-c-myc (clone 9E10) and anti-c-myc-peroxidase (Roche Applied Science, Basel, Switzerland); rabbit polyclonal anti-TH (Novus Biologicals); rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2; Epitomics Inc., Burlingame, CA, USA); rabbit polyclonal anti-LRRK2 (JH5514) raised to residues 2500–2515 [44,51]; rabbit polyclonal anti-ArfGAP1 raised to recombinant full-length human ArfGAP1 protein (Proteintech Group Inc., Chicago, IL, USA); rabbit polyclonal anti-ArfGAP1 raised to
Techniques: In Vivo, Immunoprecipitation, Construct, Knock-Out, Control
Journal: PLoS genetics
Article Title: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
doi: 10.1371/journal.pgen.1002526
Figure Lengend Snippet: Figure 2. Co-localization of LRRK2 and ArfGAP1 in mammalian cells and neurons. (A) Confocal fluorescence microscopy reveals the co- localization of FLAG-tagged human LRRK2 with YFP-tagged and endogenous ArfGAP1 within the cytoplasm and at Golgi membranes of HEK-293T cells. ArfGAP1-YFP expression induces the dispersal of the Golgi complex and localizes to Golgi-derived vesicles and within the cytoplasm, whereas endogenous ArfGAP1 localizes to the intact Golgi complex (arrowheads) and at lower levels within the cytoplasm. Scale bars: 10 mm. (B) Similar co- localization of FLAG-LRRK2 with ArfGAP1-YFP or endogenous ArfGAP1 within the cytoplasm and at Golgi membranes (arrowheads) in rat primary cortical neurons. Cytofluorograms and co-localization coefficients (Rcoloc) reveal the extent of co-localization between LRRK2 and ArfGAP1 fluorescence signals with strongest correlation between LRRK2 and ArfGAP1-YFP in HEK-293T cells, and LRRK2 and endogenous ArfGAP1 in cortical neurons. Confocal images are taken from single z-plane at 0.1 mm thickness. Images are representative of at least three independent transfection experiments. Scale bars: 10 mm. (C) Subcellular fractionation of HEK-293T cells expressing ArfGAP1-YFP and FLAG-LRRK2. LRRK2 and ArfGAP1 are detected together in multiple subcellular fractions including soluble cytosolic (S1-S3), heavy (P2, mitochondria/TIM23) and light (P3, Golgi/GM130) membrane fractions (left panels). ArfGAP1-YFP interacts with FLAG-LRRK2 in the membrane-deficient soluble cytosolic fraction (S3) following IP with anti-FLAG antibody (right panel). Molecular mass markers are indicated in kilodalton (kDa). Blots are representative of at least two independent experiments. doi:10.1371/journal.pgen.1002526.g002
Article Snippet: The following antibodies were employed: mouse monoclonal anti-FLAG-(M2), anti-FLAG-(M2)peroxidase, anti-TH (clone TH-2), anti-MAP2 (clone HM-2) and anti-b-tubulin (clone TUB 2.1), and rabbit polyclonal anti-MAP2 and reagent grade IgG from rabbit serum (Sigma-Aldrich, Buchs, Switzerland); mouse monoclonal anti-GFP (clones 7.1 and 13.1), anti-c-myc (clone 9E10) and anti-c-myc-peroxidase (Roche Applied Science, Basel, Switzerland); rabbit polyclonal anti-TH (Novus Biologicals); rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2; Epitomics Inc., Burlingame, CA, USA); rabbit polyclonal anti-LRRK2 (JH5514) raised to residues 2500–2515 [44,51]; rabbit polyclonal anti-ArfGAP1 raised to recombinant full-length human ArfGAP1 protein (Proteintech Group Inc., Chicago, IL, USA); rabbit polyclonal anti-ArfGAP1 raised to
Techniques: Fluorescence, Microscopy, Expressing, Derivative Assay, Transfection, Fractionation, Membrane
Journal: PLoS genetics
Article Title: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
doi: 10.1371/journal.pgen.1002526
Figure Lengend Snippet: Figure 4. Familial PD–associated and functional mutations in LRRK2 modulate the interaction with ArfGAP1. (A) Differential interaction of YFP-tagged ArfGAP1 with WT and PD-associated mutant forms of FLAG-tagged human LRRK2 following IP with anti-FLAG antibody from HEK-293T cells. Densitometric analysis reveals a non-significant increase in the interaction of ArfGAP1 with R1441C, Y1699C and G2019S LRRK2 compared to WT LRRK2. (B) Functional GTPase mutations in FLAG-LRRK2 impair the interaction with ArfGAP1-YFP following IP with anti-FLAG antibody from HEK-293T cells. Densitometry reveals a significant reduction of the interaction of ArfGAP1 with T1348N and R1398L LRRK2 compared to WT LRRK2. Data represent the level of interaction of ArfGAP1 with LRRK2 expressed as a percent of the interaction with WT LRRK2. The levels of ArfGAP1 IP were first normalized to ArfGAP1 input levels, and then further normalized to LRRK2 IP levels. Bars represent the mean 6 SEM (n = 3 experiments). *P,0.05 compared to WT LRRK2 by one-way ANOVA with Newman-Keuls post-hoc analysis. ns, non-significant. doi:10.1371/journal.pgen.1002526.g004
Article Snippet: The following antibodies were employed: mouse monoclonal anti-FLAG-(M2), anti-FLAG-(M2)peroxidase, anti-TH (clone TH-2), anti-MAP2 (clone HM-2) and anti-b-tubulin (clone TUB 2.1), and rabbit polyclonal anti-MAP2 and reagent grade IgG from rabbit serum (Sigma-Aldrich, Buchs, Switzerland); mouse monoclonal anti-GFP (clones 7.1 and 13.1), anti-c-myc (clone 9E10) and anti-c-myc-peroxidase (Roche Applied Science, Basel, Switzerland); rabbit polyclonal anti-TH (Novus Biologicals); rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2; Epitomics Inc., Burlingame, CA, USA); rabbit polyclonal anti-LRRK2 (JH5514) raised to residues 2500–2515 [44,51]; rabbit polyclonal anti-ArfGAP1 raised to recombinant full-length human ArfGAP1 protein (Proteintech Group Inc., Chicago, IL, USA); rabbit polyclonal anti-ArfGAP1 raised to
Techniques: Functional Assay, Mutagenesis
Journal: PLoS genetics
Article Title: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
doi: 10.1371/journal.pgen.1002526
Figure Lengend Snippet: Figure 5. ArfGAP1 is expressed in the mammalian brain. (A) Western blot analysis of ArfGAP1 protein levels in mouse brain, with highest levels detected in cerebral cortex (Ctx) and cerebellum (Cb), moderate levels in striatum (Str) and ventral midbrain (VMB), and lowest levels in olfactory bulb (Olf) and spinal cord (SC). LRRK2 is detected at highest levels in striatum, cortex and cerebellum. b-tubulin indicates equivalent protein loading. (B) Subcellular fractionation of mouse whole brain tissue. ArfGAP1 is broadly detected with particular enrichment in membrane-associated fractions including the heavy (P2) and synaptosomal (LP1) membrane fractions, and soluble cytosolic (S1 and S3) and synaptosomal cytosolic (LS1) fractions.
Article Snippet: The following antibodies were employed: mouse monoclonal anti-FLAG-(M2), anti-FLAG-(M2)peroxidase, anti-TH (clone TH-2), anti-MAP2 (clone HM-2) and anti-b-tubulin (clone TUB 2.1), and rabbit polyclonal anti-MAP2 and reagent grade IgG from rabbit serum (Sigma-Aldrich, Buchs, Switzerland); mouse monoclonal anti-GFP (clones 7.1 and 13.1), anti-c-myc (clone 9E10) and anti-c-myc-peroxidase (Roche Applied Science, Basel, Switzerland); rabbit polyclonal anti-TH (Novus Biologicals); rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2; Epitomics Inc., Burlingame, CA, USA); rabbit polyclonal anti-LRRK2 (JH5514) raised to residues 2500–2515 [44,51]; rabbit polyclonal anti-ArfGAP1 raised to recombinant full-length human ArfGAP1 protein (Proteintech Group Inc., Chicago, IL, USA); rabbit polyclonal anti-ArfGAP1 raised to
Techniques: Western Blot, Fractionation, Membrane
Journal: PLoS genetics
Article Title: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
doi: 10.1371/journal.pgen.1002526
Figure Lengend Snippet: Figure 6. ArfGAP1 enhances the GTP hydrolysis activity of LRRK2. (A) ArfGAP1-YFP expression fails to influence the steady-state levels of FLAG-tagged WT LRRK2 bound to GTP following pull-down assays with GTP-sepharose from HEK-293T cells. (B) Confirmation of the specificity of LRRK2 GTP binding is indicated by negligible binding of the GDP/GTP binding-deficient LRRK2 mutant, T1348N. Competition with an excess of free GTP (2 mM) abolishes binding of WT LRRK2 to GTP-sepharose in the presence or absence of ArfGAP1. Each input lysate (top panel) was split equally and used for GTP pull-down assays in the presence or absence of free GTP (lower panel), as indicated. (C) ArfGAP1-YFP expression fails to influence the steady-state levels of GTP-bound WT and PD-associated mutant LRRK2. Densitometric analysis reveals a significant increase in GTP binding of the R1441C and Y1699C LRRK2 variants compared to WT LRRK2, independent of ArfGAP1 expression. Data represent the level of LRRK2 GTP binding expressed as a percent of WT LRRK2 levels. GTP-bound LRRK2 levels were normalized to LRRK2 input levels. Bars represent the mean 6 SEM (n = 3 experiments). *P,0.05 and **P,0.01 compared to WT LRRK2 by one-way ANOVA with Newman-Keuls post-hoc analysis. (D) GTP hydrolysis activity of Arf1 in the presence or absence of full-length ArfGAP1 was determined by measuring the concentration of free phosphate (Pi) released from GTP. WT ArfGAP1 enhances Arf1-mediated GTP hydrolysis whereas DN ArfGAP1 has negligible effects on Arf1. The input levels of immunopurified Arf1-CFP and ArfGAP1-YFP variant were assessed by Western blot analysis with anti-GFP antibody (lower panel). (E) GTP hydrolysis activity of WT LRRK2 is significantly enhanced by WT ArfGAP1 but not by DN ArfGAP1. Guanine nucleotide-deficient T1348N LRRK2 exhibits impaired GTP hydrolysis activity, whereas the GTPase-hyperactive R1398L LRRK2 exhibits enhanced activity compared to WT LRRK2. The input levels of immunopurified FLAG-LRRK2 variants were assessed by Western blot analysis with anti-FLAG antibody (E, upper panel), quantified by densitometry, and used for normalization of Pi release between LRRK2 variants. GTP hydrolysis activity for Arf1 (D) or LRRK2 (E) is expressed as Pi release as a percent of Arf1 or WT LRRK2 activity alone, as indicated. Bars represent the mean 6 SEM (n = 5 experiments). *P,0.05 and **P,0.01 compared to Arf1 (D) or WT LRRK2 (E) by one-way ANOVA with Newman-Keuls post-hoc analysis. doi:10.1371/journal.pgen.1002526.g006
Article Snippet: The following antibodies were employed: mouse monoclonal anti-FLAG-(M2), anti-FLAG-(M2)peroxidase, anti-TH (clone TH-2), anti-MAP2 (clone HM-2) and anti-b-tubulin (clone TUB 2.1), and rabbit polyclonal anti-MAP2 and reagent grade IgG from rabbit serum (Sigma-Aldrich, Buchs, Switzerland); mouse monoclonal anti-GFP (clones 7.1 and 13.1), anti-c-myc (clone 9E10) and anti-c-myc-peroxidase (Roche Applied Science, Basel, Switzerland); rabbit polyclonal anti-TH (Novus Biologicals); rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2; Epitomics Inc., Burlingame, CA, USA); rabbit polyclonal anti-LRRK2 (JH5514) raised to residues 2500–2515 [44,51]; rabbit polyclonal anti-ArfGAP1 raised to recombinant full-length human ArfGAP1 protein (Proteintech Group Inc., Chicago, IL, USA); rabbit polyclonal anti-ArfGAP1 raised to
Techniques: Activity Assay, Expressing, Binding Assay, Mutagenesis, Concentration Assay, Variant Assay, Western Blot
Journal: PLoS genetics
Article Title: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
doi: 10.1371/journal.pgen.1002526
Figure Lengend Snippet: Figure 7. LRRK2 phosphorylates ArfGAP1, and ArfGAP1 enhances LRRK2 kinase activity. (A) In vitro kinase assay with [32P]-c-ATP, recombinant WT, R1441C, G2019S or D1994A human LRRK2 (D970, residues 970–2527) and GST-tagged ArfGAP1. Silver-stained SDS-PAGE gels indicate equal loading of ArfGAP1 and LRRK2 proteins in each condition. Autoradiographs show the LRRK2-dependent phosphorylation of ArfGAP1, with enhanced phosphorylation by G2019S LRRK2 compared to WT protein. LRRK2 autophosphorylation is also detected in this assay. Molecular mass markers are indicated in kilodaltons (kDa). (B) Michaelis-Menten kinetics of ArfGAP1 as a LRRK2 substrate. Reactions were run for 30 min in the presence of 2 nM WT-LRRK2 enzyme and the indicated concentration of ArfGAP1. Incorporation of phosphate into ArfGAP1 was determined by SDS- PAGE followed by densitometry from a phosphoscreen. (C) In vitro radioactive kinase assay using recombinant D970-LRRK2 variants and LRRKtide peptide as a LRRK2 substrate. WT, R1441C and G2019S LRRK2 phosphorylate LRRKtide at levels correlating with LRRK2 autophosphorylation, whereas kinase-dead D1994A shows minimal activity towards LRRKtide. ArfGAP1 significantly enhances LRRKtide phosphorylation by LRRK2 variants. Data represent the level of LRRKtide phosphorylation expressed as 32P incorporation in radioactive counts per minute (CPM). Bars represent the mean 6 SEM (n = 4 experiments). ***P,0.001 comparing the absence or presence of ArfGAP1 for each LRRK2 variant by one-way ANOVA with Newman-Keuls post-hoc analysis. ns, non-significant. doi:10.1371/journal.pgen.1002526.g007
Article Snippet: The following antibodies were employed: mouse monoclonal anti-FLAG-(M2), anti-FLAG-(M2)peroxidase, anti-TH (clone TH-2), anti-MAP2 (clone HM-2) and anti-b-tubulin (clone TUB 2.1), and rabbit polyclonal anti-MAP2 and reagent grade IgG from rabbit serum (Sigma-Aldrich, Buchs, Switzerland); mouse monoclonal anti-GFP (clones 7.1 and 13.1), anti-c-myc (clone 9E10) and anti-c-myc-peroxidase (Roche Applied Science, Basel, Switzerland); rabbit polyclonal anti-TH (Novus Biologicals); rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2; Epitomics Inc., Burlingame, CA, USA); rabbit polyclonal anti-LRRK2 (JH5514) raised to residues 2500–2515 [44,51]; rabbit polyclonal anti-ArfGAP1 raised to recombinant full-length human ArfGAP1 protein (Proteintech Group Inc., Chicago, IL, USA); rabbit polyclonal anti-ArfGAP1 raised to
Techniques: Activity Assay, In Vitro, Kinase Assay, Recombinant, Staining, SDS Page, Phospho-proteomics, Concentration Assay, Variant Assay
Journal: PLoS genetics
Article Title: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
doi: 10.1371/journal.pgen.1002526
Figure Lengend Snippet: Figure 9. Silencing of ArfGAP1 expression rescues G2019S LRRK2-induced neurite shortening. (A) Primary cortical neurons were infected with lentiviral vectors expressing shRNAs (non-silencing control or ArfGAP1-specific) at DIV 2, subsequently transfected with FLAG-LRRK2 (WT or G2019S) and GFP constructs at a 10:1 molar ratio at DIV 3, and fixed at DIV 6. Fluorescent microscopic images reveal the co-labeling of cortical neurons with FLAG-LRRK2 and GFP. The knockdown of endogenous ArfGAP1 fluorescence signal is also shown following lentiviral expression of ArfGAP1-specific shRNA (LV-sh-ArfGAP1 #2) compared to control shRNA (LV-sh-control). GFP images were pseudo-colored with ICA for neurite length measurements. Neuronal soma (arrows) and axonal processes (arrowheads) are indicated. Scale bars: 400 mm. (B) Analysis of GFP-positive axonal processes reveals a robust shortening of axons induced by G2019S LRRK2 expression, and a smaller effect induced by WT LRRK2, compared to GFP alone (control). Knockdown of ArfGAP1 with lentiviral-shRNA vectors produces a complete rescue of G2019S LRRK2-induced axon shortening and a partial rescue of WT LRRK2-induced shortening, compared to control shRNA. Bars represent mean (6 SEM) length of axons expressed as a percent of GFP alone (control/LV-sh-control) from .60 GFP-positive neurons from at least two independent experiments/cultures. ***P,0.001 comparing LV- sh-ArfGAP1 with LV-sh-control for G2019S LRRK2 by one-way ANOVA with Newman-Keuls post-hoc analysis. ns, non-significant. doi:10.1371/journal.pgen.1002526.g009
Article Snippet: The following antibodies were employed: mouse monoclonal anti-FLAG-(M2), anti-FLAG-(M2)peroxidase, anti-TH (clone TH-2), anti-MAP2 (clone HM-2) and anti-b-tubulin (clone TUB 2.1), and rabbit polyclonal anti-MAP2 and reagent grade IgG from rabbit serum (Sigma-Aldrich, Buchs, Switzerland); mouse monoclonal anti-GFP (clones 7.1 and 13.1), anti-c-myc (clone 9E10) and anti-c-myc-peroxidase (Roche Applied Science, Basel, Switzerland); rabbit polyclonal anti-TH (Novus Biologicals); rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2; Epitomics Inc., Burlingame, CA, USA); rabbit polyclonal anti-LRRK2 (JH5514) raised to residues 2500–2515 [44,51]; rabbit polyclonal anti-ArfGAP1 raised to recombinant full-length human ArfGAP1 protein (Proteintech Group Inc., Chicago, IL, USA); rabbit polyclonal anti-ArfGAP1 raised to
Techniques: Expressing, Infection, Control, Transfection, Construct, Labeling, Knockdown, Fluorescence, shRNA
Journal: PLoS genetics
Article Title: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
doi: 10.1371/journal.pgen.1002526
Figure Lengend Snippet: Figure 11. Silencing of LRRK2 expression rescues ArfGAP1-induced neurite shortening. (A) Validation of short hairpin RNA (shRNA)- mediated silencing of endogenous LRRK2 expression in rat primary cortical neuronal cultures. Lentiviral vectors expressing non-silencing shRNA (LV- sh-control) or LRRK2-specific shRNA (LV-sh-LRRK2) were used to infect primary neurons at increasing viral doses ranging from 1.66 to 25 ng of P24 antigen per ml of media. Western blot analysis of neuronal extracts reveals the viral dose-dependent knockdown of LRRK2 with LRRK2-specific shRNAs but not control shRNA using two independent rabbit LRRK2 antibodies (MJFF-2/c41-2 or JH5514). b-tubulin indicates equivalent protein loading. (B) Silencing of endogenous LRRK2 expression in GFP-labeled cortical neurons with lentiviral-shRNA vectors revealed by confocal fluorescence microscopy with a rabbit anti-LRRK2 antibody (JH5514). (C) Primary cortical neurons were infected with lentiviral vectors expressing shRNAs (non-silencing control or LRRK2-specific) at DIV 2, subsequently transfected with ArfGAP1-YFP and DsRed constructs at a 10:1 molar ratio at DIV 3, and fixed at DIV 6. Fluorescent microscopic images reveal the co-labeling of cortical neurons with ArfGAP1-YFP and DsRed. DsRed images were pseudo-colored with ICA for neurite length measurements. Neuronal soma (arrows) and axonal processes (arrowheads) are indicated. Scale bars: 400 mm. (D) Analysis of DsRed-positive axonal processes reveals a robust shortening of axons induced by ArfGAP1 expression and increased axon length induced by silencing of LRRK2 with LV-sh-LRRK2 vector, compared to DsRed alone (control). Silencing of LRRK2 with LV-sh-LRRK2 produces a partial rescue of ArfGAP1-induced axon shortening compared to LV-sh-control. Bars represent mean (6 SEM) length of axons expressed as a percent of DsRed alone (control/LV-sh-control) from .85 DsRed-positive neurons from two independent experiments/cultures. **P,0.01 and ***P,0.001 compared to control (LV-sh-control/DsRed alone), or by comparison of ArfGAP1/LV-sh-control with ArfGAP1/LV-sh-LRRK2, by one-way ANOVA with Newman-Keuls post-hoc analysis. ns, non-significant. doi:10.1371/journal.pgen.1002526.g011
Article Snippet: The following antibodies were employed: mouse monoclonal anti-FLAG-(M2), anti-FLAG-(M2)peroxidase, anti-TH (clone TH-2), anti-MAP2 (clone HM-2) and anti-b-tubulin (clone TUB 2.1), and rabbit polyclonal anti-MAP2 and reagent grade IgG from rabbit serum (Sigma-Aldrich, Buchs, Switzerland); mouse monoclonal anti-GFP (clones 7.1 and 13.1), anti-c-myc (clone 9E10) and anti-c-myc-peroxidase (Roche Applied Science, Basel, Switzerland); rabbit polyclonal anti-TH (Novus Biologicals); rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2; Epitomics Inc., Burlingame, CA, USA); rabbit polyclonal anti-LRRK2 (JH5514) raised to residues 2500–2515 [44,51]; rabbit polyclonal anti-ArfGAP1 raised to recombinant full-length human ArfGAP1 protein (Proteintech Group Inc., Chicago, IL, USA); rabbit polyclonal anti-ArfGAP1 raised to
Techniques: Expressing, Biomarker Discovery, shRNA, Control, Western Blot, Knockdown, Labeling, Fluorescence, Microscopy, Infection, Transfection, Construct, Plasmid Preparation, Comparison
Journal: bioRxiv
Article Title: Overwriting an instinct: visual cortex instructs learning to suppress fear responses
doi: 10.1101/2024.07.31.605567
Figure Lengend Snippet: (A) Left, Schematic of injection cannula implant in the vLGN. Right, Coronal section with an example injection. Scale bar 1 mm. (B) Left, Schematic of the task design. Right: Boxplot (with median and IQR) of post-learning escape probabilities for different reagents injected before the learning protocol; injection of saline in vLGN (13 mice), mGluR5 antagonist MTEP injection in hippocampus (P = 0.740, 7 mice), MTEP injection in vLGN (P = 0.001, 15 mice), eCB synthesis blockers LEI401 and DO34 injection in vLGN (P = 0.0004, 6 mice), and CB1 receptor antagonist Rimonabant injection in vLGN (P=0.0008, 7 mice). KW test followed by Tukey HSD for all conditions. Dots indicate individual animals (C) Left, experimental approach to visualize vLGN neurons receiving input from plHVAs (vLGN plHVA neurons). Right, example of a recorded vLGN plHVA neuron under the microscope. Scale bar 30 µm. (D) Left, Schematic of in-vitro whole-cell recordings from identified vLGN plHVA neurons with bath application of eCB agonist WIN55212-2. Right, boxplots of frequency and amplitude of sIPSCs recorded with and without bath application of the eCB agonist (Freq: P = 0.003; Amp: P = 0.603; paired t-test; n = 12 cells from 4 mice). Dots indicate individual neurons. (E) Top, schematic of whole-cell recordings from identified vLGN plHVA neurons in brain slices from mice before and after learning. Bottom, Membrane potential traces of example neurons in response to current injections of different amplitudes. (F) Example traces of spontaneous inhibitory postsynaptic currents (sIPSCs) under voltage-clamp in vLGN plHVA neurons before (green) or after learning (purple). (G) Boxplots of frequency and amplitude of sIPSCs recorded from mice before and after learning (Freq P = 0.002; Amp P = 0.827 KW test; n = 20 cells from 4 mice before learning, 39 cells from 5 mice after learning). Dots indicate individual neurons. (H) Schematic of the mechanism underlying learnt suppression of escape responses: eCB-mediated inhibitory-LTD of presynaptic inhibition onto vLGN plHVA neurons, likely induced via depolarization induced by direct visual looming stimulus input combined with input from plHVAs. Statistical significance is indicated as **P < 0.001 *** P < 0.001.
Article Snippet: MTEP (CAS 329205-68-7,1 mg);
Techniques: Injection, Saline, Microscopy, In Vitro, Membrane, Inhibition
Journal: Nature Communications
Article Title: Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
doi: 10.1038/s41467-018-05850-w
Figure Lengend Snippet: MKK4 and MKK7 are required for GT-induced anoikis. a Western blot analysis of total extracts of human bronchial epithelial cells (BEAS-2B) showing increased phosphorylation of MKK4 (Ser257/Thr261) (pMKK4) and MKK7 (Ser271/Thr275) (pMKK7) as well as PARP cleavage (PARP/cPARP) after GT treatment for 4 and 6 h. b Western blot analysis showing increased phosphorylation of JNK (T183/Y185) (pJNK) and Bim (T112/S114) (pBim) and enhanced processing of caspase-3 and PARP in total extracts of WT MEFs treated with GT for 4 and 6 h. None of these changes were seen in the extracts of non-treated (NT) cells or MEFs deficient for both Mkk4 and Mkk7 ( Mkk4 −/− /Mkk7 −/− ). c , d MEFs deficient for either Mkk4 ( Mkk4 −/− ), Mkk7 ( Mkk7 −/− ) or both Mkk4/Mkk7 ( Mkk4 −/− /Mkk7 −/− ) exerted reduced caspase-3/7 activity ( c ) and annexin V-FITC staining ( d ) and as compared to wild-type (WT) cells when treated with GT for 6 h. e Schematic representation of how GT activates MKK4/MKK7 (MKK) and triggers JNK/Bim-mediated anoikis. Tubulin was used as loading control in a and b . Graphs in c and d show the means of at least three independent experiments ± s.e.m.; p -values: *0.05–0.01, **0.01–0.001, ***<0.001; two-way ANOVA, post hoc: Bonferroni compared to WT
Article Snippet: Membranes were probed for the proteins of interest using the following antibodies: FAK D2R2E (#13009); phospho FAK (pFAK Tyr397) (#8556); paxillin D9G12 (#12065); phospho paxillin (pPaxillin Tyr118) (#2541); MKK4 (#9152);
Techniques: Western Blot, Phospho-proteomics, Activity Assay, Staining, Control
Journal: Nature Communications
Article Title: Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
doi: 10.1038/s41467-018-05850-w
Figure Lengend Snippet: ROCK is required for GT-induced anoikis. a , b Western blot analysis showing that the pre-treatment of BEAS-2B cells with the ROCK inhibitors H-1152 (1 µM) or Y-27632 (1 µM) abrogated GT-induced JNK phosphorylation and caspase-3 and PARP processing ( a ) as well as Bim phosphorylation ( b ). Treatment with 25 µM QVD prevented caspase-3 and PARP processing but not JNK phosphorylation. c Western blot analysis showing that the pre-treatment of MEFs with the ROCK inhibitor H-1152 diminished GT-induced MKK4 and JNK phosphorylation, Bim phosphorylation and caspase-3 processing. d , e Both ROCK inhibitors prevented GT-induced caspase-3/7 activity ( d ) and apoptosis (as measured by annexin V-FITC staining) ( e ) in MEFs to the same extent as the general caspase inhibitor QVD (25 µM). f Schematic representation of how GT activates ROCK and triggers a MKK4/MKK7-JNK-Bim-mediated anoikis signalling pathway. Tubulin ( a ) and actin ( b , c ) were used as loading controls. Graphs in d and e show the means of at least three independent experiments ± s.e.m.; p -values: ***<0.001, one-way ANOVA, post hoc: Bonferroni compared to GT
Article Snippet: Membranes were probed for the proteins of interest using the following antibodies: FAK D2R2E (#13009); phospho FAK (pFAK Tyr397) (#8556); paxillin D9G12 (#12065); phospho paxillin (pPaxillin Tyr118) (#2541); MKK4 (#9152);
Techniques: Western Blot, Phospho-proteomics, Activity Assay, Staining
Journal: Nature Communications
Article Title: Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
doi: 10.1038/s41467-018-05850-w
Figure Lengend Snippet: GT triggers RhoA and subsequent ROCK activation. a Anti-RhoA western blot analysis showing the pulldown of active RhoA-GTP with GST-Rhotekin beads from total extracts of BEAS-2B cells either treated with 1 µM GT for 20, 40, 60 and 180 min or with the bacterial toxin CNFy for 4 h (positive control). The left side of the western blots shows equal RhoA input for each pulldown. b Western blot analysis of total extracts of BEAS-2B cells either untreated (NT) or treated with 1 µM GT in the absence or presence of the RhoA-inhibiting C3 toxin for 6 h showing a diminishment of GT-induced MKK4 and JNK phosphorylation by the C3 toxin. c Western blot analysis of total extracts of BEAS-2B cells treated with 2 µM GT in the absence or presence of the C3 toxin for 4 h showing that the toxin diminishes GT-induced Bim phosphorylation at T112/S114 (pBim). d Anti-MYPT1 and pMYPT1 western blot analysis of total extracts of BEAS-2B cells either untreated (NT) or treated with 1.5 µM GT in the absence or presence of the C3 toxin for 1–4 h showing that the toxin ablated the GT-induced phosphorylation of the ROCK substrate MYPT1. e Lumi Imager FusionSL Vilber Lourmat quantification of the chemiluminescent immunoblot bands shown in d . f Schematic representation of how GT activates RhoA and subsequently triggers a ROCK-MKK4/MKK7-JNK-Bim-dependent anoikis signalling pathway. Actin ( b , c ) and tubulin ( a , d ) were used as loading controls. Graph in e shows the means of at least three independent experiments ± s.e.m.; p -values: *0.05–0.01, one-way ANOVA, post hoc: Bonferroni compared to GT
Article Snippet: Membranes were probed for the proteins of interest using the following antibodies: FAK D2R2E (#13009); phospho FAK (pFAK Tyr397) (#8556); paxillin D9G12 (#12065); phospho paxillin (pPaxillin Tyr118) (#2541); MKK4 (#9152);
Techniques: Activation Assay, Western Blot, Positive Control, Phospho-proteomics
Journal: Nature Communications
Article Title: Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
doi: 10.1038/s41467-018-05850-w
Figure Lengend Snippet: FAK and p190RhoGAP are inactivated by GT. a Western blot analysis of total extracts of BEAS-2B cells either untreated (NT) or treated with 1 µM GT for the indicated time periods showing that the activating phosphorylation of FAK at Y397 (pFAK) was lost within 1 h. b Paxillin (pPax) was dephosphorylated and degraded and JNK was phosphorylated/activated (pJNK) with the same kinetics as FAK inactivation. c Concomitantly, p190RhoGAP was also dephosphorylated at Y1105. d Treating BEAS-2B cells with 10 µM of the specific FAK inhibitor FAK14 caused rapid cell detachment within 6 h. Scale bar = 100 µm. e , f Cell survival of BEAS-2B cells measured as relative metabolic activity using the XTT assay gradually decreased with increasing doses of FAK14 (0–10 µM) ( e ). Concomitantly, 50 µM FAK14 triggered cell death of BEAS-2B cells (as measured by annexin V-FITC staining) with similar time kinetics as GT ( f ). g Western blot analysis of total extracts of BEAS-2B cells either non-treated (NT) or treated with 50 µM of FAK14 ( g ) or 10 µM of FAK14 ( h ) for 30 min to 4 h. The inhibitor caused FAK and p190RhoGAP dephosphorylation and MKK4, JNK and Bim phosphorylations. Tubulin was used as loading control in a – c , g and h . i FAK is active in adherent epithelial cells causing the activation of p190RhoGAP by its phosphorylation at Y1105. This inactivates RhoA. In response to GT, FAK and p190RhoGAP get inactivated, therefore allowing RhoA activation. Graphs in e and f show the means of at least three independent experiments ± s.e.m.; p -values: *0.05–0.01, **0.01–0.001, ***<0.001, one-way ANOVA, post hoc: Bonferroni compared to NT
Article Snippet: Membranes were probed for the proteins of interest using the following antibodies: FAK D2R2E (#13009); phospho FAK (pFAK Tyr397) (#8556); paxillin D9G12 (#12065); phospho paxillin (pPaxillin Tyr118) (#2541); MKK4 (#9152);
Techniques: Western Blot, Phospho-proteomics, Activity Assay, XTT Assay, Staining, De-Phosphorylation Assay, Control, Activation Assay
Journal: Nature Communications
Article Title: Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
doi: 10.1038/s41467-018-05850-w
Figure Lengend Snippet: GT diminishes RGD binding and surface expression of integrins. a The binding capacity of integrins to extracellular matrix components was measured on untreated (NT) and GT-treated BEAS-2B cells by FACS analysis of RGD-FAM peptide staining. b , c Adherent human lung epithelial cells (BEAS-2B) or MEFs showed reduced surface expression of integrin β3 ( b ) or integrin β1 ( c ), respectively, after 2–6 h of GT treatment as evidenced by FACS analysis of anti-integrin-stained cells. Human Jurkat ( b ) or mouse BAF or FL5.12 suspension cells ( c ) did not show such a reduction although they expressed integrins on their surface (Supplementary Fig. and ), most likely in an inactive form (Supplementary Fig. ). d While BEAS-2B cells underwent apoptosis (as determined by annexin V-FITC FACS analysis) after 1 µM GT treatment for 6 h, this was not the case for BAF3, Jurkat or FL5.12 suspension cells. e Western blot analysis of total extracts of BEAS-2B cells (first lane) or BAF3 cells either untreated (NT) or treated with 1 µM GT for 6 h showing that GT did not cause phosphorylation/activation of MKK4 and JNK in BAF3 but does so in BEAS-2B cells. Actin was used a loading control. Graphs in a – d show the means of at least three independent experiments ± s.e.m.; p -values: *0.05–0.01, **0.01–0.001, ***<0.001, two-way ANOVA, post hoc: Bonferroni compared to NT
Article Snippet: Membranes were probed for the proteins of interest using the following antibodies: FAK D2R2E (#13009); phospho FAK (pFAK Tyr397) (#8556); paxillin D9G12 (#12065); phospho paxillin (pPaxillin Tyr118) (#2541); MKK4 (#9152);
Techniques: Binding Assay, Expressing, Staining, Suspension, Western Blot, Phospho-proteomics, Activation Assay, Control
Journal: Nature Communications
Article Title: Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
doi: 10.1038/s41467-018-05850-w
Figure Lengend Snippet: Induction of integrins by PMA confers sensitivity to anoikis. a Phase contrast microscopy analysis of K562 cells treated with 10 ng/ml PMA for 96 h before adding 1 μM GT for 6 h. While untreated (NT) cells grow in suspension, PMA-treated cells adhere to the dish and become sensitive to GT-induced detachment. Scale bar = 100 µm. b GT induced caspase-3/-7 activity (taken as 100%) in PMA-treated adherent K562 cells (+PMA) but not in undifferentiated suspension cells (−PMA). c , d FACS analysis of K562 cells showing that PMA increased the surface expression of integrin β3 ( c ) and an active form of integrin β1 (using the anti-active integrin β1 12G10 Alexa Fluor ® 488) ( d ). Iso: respective Ig control-FITC antibody. e Western blot analysis of total extracts of undifferentiated (−PMA) and differentiated (+PMA) K562 cells either untreated (NT) or treated with 1 µM GT for 6 h showing that PMA induced the expression of integrin (INTG) αV, β1 and β3. GT triggered the phosphorylation of MKK4, JNK and Bim (as evidence by a gel shift) as well as caspase-3 processing, but only in PMA-treated cells. Tubulin was used a loading control. Graphs in b – d show the means of at least three independent experiments ± s.e.m.; p -value: ***<0.001, two-way ANOVA, post hoc: Bonferroni compared to non-treated (NT)
Article Snippet: Membranes were probed for the proteins of interest using the following antibodies: FAK D2R2E (#13009); phospho FAK (pFAK Tyr397) (#8556); paxillin D9G12 (#12065); phospho paxillin (pPaxillin Tyr118) (#2541); MKK4 (#9152);
Techniques: Microscopy, Suspension, Activity Assay, Expressing, Control, Western Blot, Phospho-proteomics, Gel Shift
Journal: Nature Communications
Article Title: Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
doi: 10.1038/s41467-018-05850-w
Figure Lengend Snippet: GT-induced anoikis signalling. FAK is recruited to focal adhesions via paxillin and is active in healthy adhesion cells. Active FAK phosphorylates p190RhoGAP. Phosphorylated p190RhoGAP stimulates the GTPase activity of RhoA. RhoA and the downstream anoikis-inducing cascade is therefore inactive (left). GT inactivates integrins, possibly by covalent binding to cysteines in the N-terminal region of α and β chains and triggers the disassembly of focal adhesions. Paxillin is degraded and FAK is inactivated, resulting in inactive p190RhoGAP. RhoA is consequently active and induces anoikis via a kinase cascade from ROCK to MKK4/MKK7 to JNK, resulting in the pro-apoptotic triple phosphorylation of Bim (right). Inhibitory integrin antibodies such as Cilengitide or FAK inhibitors such as FAK14 can induce the same anoikis signalling pathway
Article Snippet: Membranes were probed for the proteins of interest using the following antibodies: FAK D2R2E (#13009); phospho FAK (pFAK Tyr397) (#8556); paxillin D9G12 (#12065); phospho paxillin (pPaxillin Tyr118) (#2541); MKK4 (#9152);
Techniques: Activity Assay, Binding Assay, Phospho-proteomics